key: cord-0283444-fxbetcu4
authors: Miranda de Paiva, B. B.; Pereira, P. D.; de Andrade, C. M. V.; Gomes, V. M. R.; Lima, M. C. P. B.; Silva, M. V. R. S.; Carneiro, M.; Martins, K. P. M. P.; Sales, T. L. S.; Carvalho, R. L. R. d.; Pires, M. C.; Ramos, L. E. F.; Silva, R. T.; Bezerra, A. F. B.; Schwarzbold, A. V.; Nunes, A. G. S.; Maurilio, A. d. O.; Scotton, A. L. B. A.; Costa, A. S. d. M.; Castro, A. A.; Farace, B. L.; Cimini, C. C. R.; De Carvalho, C. A.; Silveira, D. V.; Ponce, D.; Pereira, E. C.; Manenti, E. R. F.; Cenci, E. P. d. A.; Lucas, F. B.; Rodrigues, F. D.; Anschau, F.; Botoni, F. A.; Aranha, F. G.; Bartolazzi, F.
title: Effectiveness, Explainability and Reliability of Machine Meta-Learning Methods for Predicting Mortality in Patients with COVID-19: Results of the Brazilian COVID-19 Registry
date: 2021-11-02
journal: nan
DOI: 10.1101/2021.11.01.21265527
sha: 300f5833a722276b696893e8ffb3c5c780c9beda
doc_id: 283444
cord_uid: fxbetcu4

Objective: To provide a thorough comparative study among state ofthe art machine learning methods and statistical methods for determining in-hospital mortality in COVID 19 patients using data upon hospital admission; to study the reliability of the predictions of the most effective methods by correlating the probability of the outcome and the accuracy of the methods; to investigate how explainable are the predictions produced by the most effective methods. Materials and Methods: De-identified data were obtained from COVID 19 positive patients in 36 participating hospitals, from March 1 to September 30, 2020. Demographic, comorbidity, clinical presentation and laboratory data were used as training data to develop COVID 19 mortality prediction models. Multiple machine learning and traditional statistics models were trained on this prediction task using a folded cross validation procedure, from which we assessed performance and interpretability metrics. Results: The Stacking of machine learning models improved over the previous state of the art results by more than 26% in predicting the class of interest (death), achieving 87.1% of AUROC and macroF1 of 73.9%. We also show that some machine learning models can be very interpretable and reliable, yielding more accurate predictions while providing a good explanation for the why. Conclusion: The best results were obtained using the meta learning ensemble model Stacking. State of the art explainability techniques such as SHAP values can be used to draw useful insights into the patterns learned by machine-learning algorithms. Machine learning models can be more explainable than traditional statistics models while also yielding highly reliable predictions. Key words: COVID-19; prognosis; prediction model; machine learning

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Introduction1 112 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint hospital admission, the majority of them are bounded by methodological flaws and technological 124 limitations, meaning that reliable prognostic prediction models are scarce (3-5). 125

A state-of-the-art method for this prediction task has recently been proposed by our group with the 126 development of a new risk score -ABC 2 -SPH -using traditional statistical methods (least absolute 127 shrinkage and selection operator -LASSO regression), which exploits a rich set of information, including 128 patient's demographics, comorbidities, vital signs and laboratory parameters at the time of presentation, for 129 assessing prognosis in COVID-19 patients. The model has shown high discriminatory value (AUROC In this context, artificial intelligence (AI), and more specifically machine learning (ML), techniques 134 have been explored in various fields for dealing with the pandemic, such as detecting outbreaks, diagnosis, 135 interpretation of chest imaging exams to detect COVID-19 lung disease, vaccines development and 136 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint prognosis prediction (6,7), but comprehensive comparative studies to investigate whether ML techniques 137 have superior performance when compared to models using traditional statistical methods are still scarce. 138

Indeed in several other contexts (8) ML techniques have demonstrated superior effectiveness (i.e., 139 accuracy) when compared to traditional statistical methods (e.g., logistic regression), due for instance, their 140 capability of dealing with collinearity and redundancy, as well the ability to find non-linear correlations 141 among the variables. However, current studies in the mortality prediction for COVID-19 using ML 142 techniques are limited, regarding either methodological or technological aspects. 143

In this scenario, the contributions of this article are fivefold. First, we provide a thorough 144 comparative study among state-of-the-art ML methods, including many modern techniques, such as 145 transformer and convolutional neural networks, boosting algorithms, support vector machines (SVM), k-146 nearest neighbors, as well as state-of-the-art statistical methods, represented by ABC 2 -SPH, in the task of 147 determining in-hospital mortality in COVID-19 patients using data upon hospital admission. 148 Second, given the profusion and diversity of the compared methods, we investigate the 149 effectiveness of meta-learning ensemble strategies, most notably Stacking (9), that combine the methods' 150 outputs (probabilities), in order to exploit the ML methods' strengths and overcome their limitations. 151

Third, we study the reliability of the predictions of the most effective methods by correlating the 152 probability of the outcome and the effectiveness (accuracy) of the methods. Few studies have investigated 153 this important aspect of the predictions, which has practical impact in the applicability of the methods. 154

Fourth, we investigated how interpretable (or explainable) are the predictions produced by the most 155 effective methods using modern interpretability tools. Explainability is an essential aspect of the task if ML 156 methods are to be trusted and actually used by practitioners. 157

Finally, we provide a discussion on the adequacy of AUROC as an evaluation metric for highly 158 imbalanced and skewed datasets commonly found in health-related problems, as is the case of our COVID-159 19 study. 160 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint for COVID-19 mortality using artificial intelligence techniques. These models were identified through a 163 literature search of Medline and MedRxiv, with no language or date restrictions, using the search not 164 indexed terms: "COVID-19", "SARS-CoV-2", combined with "mortality", "prognosis", "risk factors", 165 "hospitalizations" or "score". The last search was performed in August 2021. 166

Following the narrative analysis, our initial search highlighted papers that satisfied our search 167 criteria, removing duplicates, leaving relevant articles for the title and abstract review. Text screening 168 retained 76 studies included in the S1 Table.  169 The existing literature largely focuses on American and Chinese hospitals, represented together by 170 53.94% of studies. In fact, models validated in one country cannot be extrapolated to the population as a 171 whole, since there is heterogeneity among countries in different characteristics such as populations features 172 (including genetics, race, ethnicity, prevalence of comorbidities), socioeconomic factors, access to 173 healthcare, and the healthcare systems themselves (hospitals patient load, practice and available resources) 174 (10). 175

Another important point is the sample size. Larger population studies are needed to allow certain 176 metrics of model performance to be estimated with more accurate and reliable results. In contrast, smaller 177 samples reduce the ability to identify risk factors and increase the likelihood of overfitting (11). Among the 178 analyzed models, 17.10% were developed and validated with a modest sample of 500-1000 patients, and 179 35.52% used even a smaller sample, with less than 500 patients. Only 47.36% of the studies used a sample 180 with more than 1000 patients. Our sample used in this study has 5032 patients. 181

Most of the studies (60.52%) used traditional statistical methods, including multivariate logistic 182 regression, LASSO and Cox regression analysis. Artificial intelligence techniques were used in 39.47% of 183 studies, among them stands out machine learning, including random forest (RF), XGBoost and SVM. And 184 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) only a very small percentage (11.8%) of works exploit modern neural network methods in their studies as 185 we do in ours. 186

Overall, the majority of developed models are limited by methodological bias, with for example, 187 absence of external validation in 51.31%, so the assessment of accuracy in those studies may be 188 overestimated. A minority of them (around 23.68%) reported having followed the methodological 189 recommendations from Transparent Reporting of a multivariable prediction model for Individual Prognosis 190 Or Diagnosis (TRIPOD) (11). 191

The model performance was evaluated in most studies, by area under the curve (AUC), and the 192 mean AUC for training ranged from 0.64-0.96 for traditional statistical methods, and from 0.74-0.96 for 193 models using AI techniques. However, due to the very high skewness of the datasets (i.e., mortality 194 corresponds to a very low percentage of the cases in the datasets, in other words, the non-death class 195 dominates the distribution) neither AUC nor accuracy are adequate metrics (12). 196

To properly assess the performance of different models, it is of utmost importance to use other 197 metrics that consider imbalance issues, such as macro-average F1-score (macro-F1), used in 13.33% 198 studies. For example, Li et al (2020) developed a deep-learning model and a risk-score system based on 55 199 clinical variables and observed that the most crucial biomarkers distinguishing patients at mortality 200 imminent risk, were age, lactate dehydrogenase, procalcitonin, cardiac troponin, C-reactive protein and 201 oxygen saturation (13). The deep-learning model predicted mortality with an AUC of 0.852 and 0.844, for 202 training and testing, respectively, which is considered excellent (13). However, the performance of the 203 proposed algorithm on training and testing datasets measured by the F1-score was 0.642 and 0.616, 204 respectively (13). 205

Finally, few studies (S1 Table) deep analyzed the impact of the variables in the final model or on 206 the final model outcome. Additionally, most studies do not investigate how reliable the made predictions 207 are in terms of the correlation between the probability of the prediction and the accuracy. This analysis has 208 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted November 2, 2021.

implications on the practical use of this technology. An accurate but unreliable method has its practical 209 applicability diminished. We explicitly tackle these issues in our study.

were admitted for other reasons and developed COVID-19 symptoms during their stay (4). 217

Trained hospital staff or interns collected demographic information, clinical characteristics, 218 laboratory and outcome data from medical records. A prespecified case report form was used, applying 219

Research Electronic Data Capture (REDCap) tools (15). To ensure data quality, comprehensive data quality 220 checks were undertaken. Error checking code was developed in R to identify data entry errors, as 221 previously described (4), and the results were sent to each center for checking and correction before further 222 data analysis. 223

Variables used to develop the models were obtained upon hospital presentation. A set of potential 224 predictor features for in-hospital mortality was selected a priori, as recommended, from demographics, 225 home medications, past medical history, clinical features, and laboratory values (S2 Table) (4,11). 226 Laboratory exams were performed at the discretion of the treating physician. The ABC 2 -SPH score is 227 composed by age, blood urea nitrogen, number of comorbidities, C-reactive protein, SpO 2 /FiO 2 ratio, 228 platelet count and heart rate (4). 229

The development, validation and reporting of the models followed guidance from the TRIPOD 231 (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) 232 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint checklist and the Prediction model Risk of Bias Assessment Tool (PROBAST) (11,16). All data was fully 233 anonymized. At that time 36 Brazilian hospitals participated in the cohort, located in 17 cities, from five 234 Brazilian states (4). 235 236 A total of 5032 patients were admitted between March 1, 2020 and September 31, 2020, and the full 237 group was used to perform a 10-fold cross validation procedure, which was repeated 3 times (at a total of 238 30 performance measurements for each of the classifiers presented in our study In order to properly assess the performance of different models, we chose to use three different 242 metrics, each assessed through the aforementioned 10-fold cross validation procedure, for each classifier. 243

Our evaluation metrics include both micro-average and macro-average F1-score (micro-F1 and macro-F1), 244 and the area (AUROC) under the receiver operating curve (ROC-Curve). While more common in 245 healthcare-related literature, the AUROC values can be misleading, especially when there is significant 246 class imbalance (17) , and even more so when the class of interest is the rare one (which is usually the case). 247 Therefore, we included the micro and macro-F1 scores as evaluation metrics. The F1 score is the harmonic 248 mean between precision and recall scores, for each class (i.e. one score to estimate how well the model can 249

predict which patients will die, and one to estimate the same regarding which patients will not die). The 250 "average" part, described as either "micro" or "macro", refers to how these results are aggregated. In 251 "macro" averaging, all classes are taken as equally important, while in "micro" averaging, class imbalance 252 is not accounted for in the final result and all individual predictions are considered equally important (18). 253

As for the specific models compared in our study, we trained two modern neural network 254 benchmarks --the FNet transformer, with and without virtual adversarial training, which is a regularization 255 technique --and a deep convolutional Resnet. We also experimented with a support vector machine 256 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint the prediction outputs of all previous classifiers in order to improve classification effectiveness. We 282 compare these methods to Generalised Additive Models (GAM) and LASSO regression, the latter being the 283 current state-of-the-art model for this task, as demonstrated in our previous work. 284

We ran all classification tests using a 10 fold cross validation procedure, after which we calculated 285 confidence intervals for each result, and confirmed statistical significance by applying a Wilcoxon signed-286 rank test with 95% confidence. 287

For the parametrization of our models, we used the values presented in Table 1 FNet + VAT = fourier transformation neural network with virtual adversarial training, GAM = generalized 293 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint additive models, KNN = K-nearest neighbors, LASSO = lasso regression, LIGHT_GBM = light gradient 294 boosting machines, RF = random forest, SVM = support vector machines, STACKING = a stacking 295 classifier, which combines all others. 296

Classification results for the prediction of death can be found in Table 1 and macro-F1, and AUROC. It is interesting to notice that GAM surpassed LASSO, which was used in our 303 ABC 2 -SPH score and was considered the previous state-of-the-art. 304

The less effective results of the Neural network are somewhat expected as the size of the dataset is 305 not that huge, with fewer than 10 thousand samples. Typically, we expect neural networks of large capacity 306 (millions to billions of parameters) to excel in tasks where very large datasets are available (millions to 307 billions of training instances), which is very rare in health-related problems. In such large-scale datasets, 308 neural networks can capture very complex relationships. However, in smaller sample sizes, they show a 309 remarkable tendency to overfit, hence obtaining poor results in terms of validation error (12,19) . 310

In general, tree-based ensemble models such as random and boosting forests tend to be more robust 311 to small sample sizes and to overfitting, which is exactly the behavior we observed in our experiments (24). 312 SVM and K-nearest neighbors (KNN), which are simpler models, with fewer parameters, also tend to 313 perform reasonably well on smaller datasets being better than the neural network models. 314

We should stress that the statistical models LASSO regression and mainly Generalized additive 315 models (GAM) showed very competitive results for this data sample. Unexpectedly, GAM was the runner 316 up method considering all metrics, being even better than LASSO and some traditional ML methods such 317 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint was the Stacking model, which is a combination of the output of all other individual models, which, in 323 turn, exploited all the provided features (S2 Table) , including demographic data, comorbidities, lifestyle 324 habits, clinical assessment and laboratory data upon hospital admission: age; days from symptom onset; 325 heart and respiratory rate, mechanical ventilation, oxygen inspiration fraction, platelets, urea, C-reactive 326 protein, lactate, gasometry results (pH, pO 2 , pCO 2 , bicarbonate), hemogram parameters (hemoglobin, 327 neutrophils, lymphocytes, neutrophils to lymphocytes ratio, platelets) and sodium upon hospital 328 admission. When considering micro and macro-F1, F1 for death and AUROC at the task of predicting 329 death, Stacking was significantly (statistically) better than all other models. The largest gains were in F1 to 330 predict death with gains of up more than 26% over LASSO, the previous state-of-the-art. 331

Indeed, we observe in Table 2 that the combination of models by means of Stacking yields 332 statistically significant improvements over all the best individual single models (RF, Boosting and GAM), 333 allowing us to better discriminate between patients with higher clinical risk at admission time. The 334

Stacking technique improves the F1-score results for the class of interest (death) by 7% over RF, by 5% for 335

LightGBM and by 6% for GAM, which were the three individual best models in this metric. The 336 combination of models based on different classification premises, potentially made stacking more robust. If 337 a single classifier makes a wrong prediction, the others can still make corrections (since the predictions are 338 independent), increasing the robustness of the final stacking model. 339 Table 2 . Micro-F1, macro-F1 and AUROC results for the prediction of COVID-19 in-hospital death.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. macro-F1, or class-specific F1 scores, which shows that (1) AUROC score is not an adequate metric for 351 evaluating and comparing models, especially in face of high imbalance/skewness and that (2) even though 352 some models, like Stacking and GAM have very similar AUROC scores, their capacity to discriminate 353 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint relevant outcomes like death is quite different (0.532 F1 score for GAM end 0.564 for Stacking, a 354 significant difference of 6%). 355

Another interesting remark is that, using such curves, we can sensibly calibrate the trade-off 356 between sensitivity and specificity, further customizing the way such models can be used. In particular, 357 when applying Stacking, our model can be tailored to the early identification of high-risk patients with 358 good discrimination capacity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint is the explainability of these models. This is still a very active research area, but modern advances in tools 370 and visualization alternatives allow us to represent which features were most important to the model and at 371 which polarities and intervals. The best model in our tests was the Stacking. However, this is a meta-model 372 whose inputs are the outputs of other classifiers. Because of that, and since we want to explain a classifier 373 that works on the level of the features themselves instead of a meta-level of other classifier outputs, we will 374 provide explanations for the second best model, LightGBM. Furthermore, tree-based boosting and bagging 375 algorithms rank as some of the most explainable machine learning models, and also lead many benchmarks, 376 particularly for tabular data where data samples are not that large. Their unique combination of 377 explainability, reliability and performance, added to the fact that stacking is a meta-classifier are why we 378 will exploit the boosting model (which, in our case, outperformed the bagging model -random forests/RF) 379 to analyse the found correlations among variables. 380

In a sense, some traditional models, such as regression models, also have a good explainability, as 381 we can assess the coefficients of each attribute to measure how important a feature is. These models 382 however do not measure up to modern tree-based algorithms in many scenarios, especially in cases with 383 larger datasets (25). Another key difference between these models is that, in the case of regression models, 384 we have to explicitly remove collinear variables, but these variables, even though they might not improve 385 classification performance, still yield valid model explanations. In addition to that, tree based models can 386 return explanations in the form of intervals, such as the behavior seen in Fig 2 for sodium and bicarbonate  387 levels, which imply there is a 'safe interval' at which death risk is lower, while either extreme (i.e. too low 388 or too high) has a predictive value for the possibility of a COVID-19 related death. 389

From a clinical perspective, our results, shown in the Figures, are in line with a recent study with 390 patients from two hospitals in London, which has shown that hypernatremia and hyponatremia during 391 COVID-19 hospitalization are associated with a higher risk of death and respiratory failure, respectively 392 (26). With regards to bicarbonate, low levels are related to acidosis, and high levels are usually related to 393 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint advanced chronic obstructive pulmonary disease (COPD) with retention of carbon dioxide, both of them 394 conditions well-known to be associated with worse prognosis in clinical practice (27) (28) (29) . This sort of non-395 linearity cannot be captured by simple regression models, since we can only measure how large coefficient 396 values are, and correlate that to the importance of each feature. 397

In decision tree based algorithms, however, each node represents a feature. The closer to the root 398 (i.e. the 'first' node of each tree), the more the feature is able to differentiate the data classes. For example, 399

in Fig 2, feature 'SF ratio'' with the value less than 233 and the feature 'lactate' with a value less than 1.68 400 mmol/L results in a subset with 5.9% of the dataset where the 'death' outcome is more common. 401 in each partition in each decision tree --this coefficient is called the GINI Index. Such index and the 407 entropy score tend to isolate records that represent the most frequent class in a branch. 408 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint special type of explainability technique, which allows us to not only probe which features were important 410 to the model, but also which polarities or intervals push predictions to each of the training classes and, 411 additionally, allows us to evaluate why the model predicted any single instance (30). is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint on the explainability of machine learning models, making them even more useful, as they become more 420 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021.

Finally, we investigate issues related to the reliability of the models. Neural network models are, for 468 instance, known for having irregular error rates, regardless of prediction confidence. At the other end of the 469 spectrum, boosting and bagging models tend to have a very interesting reliability profile, with a tendency to 470 have lower error rates at high confidence scores, and higher error rates at lower confidence scores. This 471 generates a very useful perspective, in which we can tune the trade-off between accuracy and sensitivity for 472 some specific classifiers. profile with respect to its confidence score. This kind of characteristic means we can tune how many 478 patients the model will indicate, as well as how sensitive or specific that indication can be. Such tuning can 479 be tailored to any specific healthcare service, accounting for intensive care unit beds, available 480 professionals and so on. 481

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint In recent months, COVID-19 mortality prediction models were published ranging from simplified 484 scores to machine learning. Based on S1 Table, there were few prediction studies that had extensive 485 analysis utilizing AI techniques. In this study, AI techniques were compared to traditional statistical 486 methods to develop a model to predict COVID-19 mortality, considering demographic, comorbidity, 487 clinical presentation and laboratory analysis data. We observed that regarding the prediction of the class of 488 interest (death), the best individual methods was a ML one (LightGBM) closely followed by a statistical 489 model (GAM), both being better than neural network models, and both being surpassed by a meta-learning 490 ensemble model --Stacking --which was the best overall solution considering all criteria for the posed 491 prediction problem. 492

We would like to stress that, despite the fact that in medical research the AUROC is widely used as 493 the sole measure of models' discriminatory ability, our data reassured us that it is an insufficient metric for 494 evaluating and comparing models. In contrast, F1 Score is a more robust metric, especially in larger, more 495 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint

As a side effect of our study, we demonstrated that AUROC score was an insufficient metric for evaluating 505 and comparing models. Even though some models, like Stacking and GAM have very similar AUROC 506 scores, their capacity to discriminate relevant outcomes like death is quite different (0.53 F1 score for 507 GAM and 0.56 for Stacking, which yields an 5.6% difference). Finally, we investigated issues related to the 508 explainability and prediction reliability of the best ML models, concluding that they are potentially very 509 useful for practical purposes in real settings. 510

We would like to thank the hospitals which are part of this collaboration, for supporting this project: 512 Hospital Nossa Senhora da Conceição; Hospital Regional Antônio Dias; Hospital Regional de Barbacena 519 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted November 2, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted November 2, 2021. ; https://doi.org/10.1101/2021.11.01.21265527 doi: medRxiv preprint

An interactive web-based dashboard to track COVID-19 in real time. The 527 Lancet Infectious Diseases

Could new COVID variants undermine vaccines? Labs scramble to find out

Clinical risk score to 531 predict in-hospital mortality in COVID-19 patients: a retrospective cohort study

ABC2-SPH 535 risk score for in-hospital mortality in COVID-19 patients: development, external validation and 536 comparison with other available scores

Systematic 539 evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-540 19: an observational cohort study

Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results 570 from the Brazilian COVID-19 registry

PROBAST: A 576 Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies

Bad practices in evaluation methodology relevant to class-imbalanced 579 problems

Quality performance metrics in 581 multivariate classification methods for qualitative analysis

Extended pre-processing 584 pipeline for text classification: On the role of meta-feature representations, sparsification and 585 selective sampling. Information Processing & Management

LightGBM: A highly efficient gradient 592 boosting decision tree